Skip to main content
Journal of Ophthalmic Inflammation and Infection
Fig. 3 | Journal of Ophthalmic Inflammation and Infection

Fig. 3

From: Efficacy of intravitreal dexamethasone implant used as monotherapy for the treatment of macular edema in non-infectious uveitis: a retrospective analysis

Fig. 3

Duration of dexamethasone implant effect. Kaplan–Meier survival plot showing the duration of effect of the initial dexamethasone implant. The average time to relapse after one injection was 7 months. Estimates of treatment success were 77% between 4 and 7 months and 46% after 10 months. Failure was defined as a follow-up with an increase in CRT of > 10% and at least 50 μm from baseline or the need for a repeat implant within 12 months post-operatively

Back to article page